Cleveland Clinic has partnered with DASI Simulations to validate the company’s Precision TAVI tool for planning transcatheter aortic valve replacements to develop a second-generation version.
The tool generates predictive 3D simulations, allowing physicians to assess valve sizing, anatomy and procedural risks before TAVR, according to a March 24 news release. Cleveland Clinic is using the software alongside standard practices to evaluate its clinical utility in a high-volume center, a process expected to last six months to a year.
The project aims to expand the tool’s application from planning to execution, Samir Kapadia, MD, chair of cardiovascular medicine at Cleveland Clinic, said in the release. The simulations have already informed patient care decisions and is now being used in all TAVR planning cases at the institution.
The tool received FDA clearance in 2023 and has a CMS reimbursement code for use in TAVR planning. While the collaboration currently focuses on the aortic valve, future iterations may extend to mitral and tricuspid procedures, the release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
